Recruiting
Phase 3

Tasimelteon

Sponsor:

Vanda Pharmaceuticals

Code:

NCT06953869

Conditions

Insomnia Disorder

Eligibility Criteria

Sex: All

Age: 2 - 17

Healthy Volunteers: Not accepted

Interventions

Tasimelteon Oral Suspension

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-21. This information was provided to ClinicalTrials.gov by Vanda Pharmaceuticals on 2026-06-05.